171 related articles for article (PubMed ID: 16604501)
1. [A modified cytogenetic study for multiple myeloma].
Qin YW; Wei DL; Wang C; Yan SK; Gao YR; Cai Q
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):213-5. PubMed ID: 16604501
[TBL] [Abstract][Full Text] [Related]
2. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.
Gutiérrez NC; Hernández JM; García JL; Almeida J; Mateo G; González MI; Hernández J; Fernández-Calvo J; San Miguel JF
Haematologica; 2000 Nov; 85(11):1146-52. PubMed ID: 11064466
[TBL] [Abstract][Full Text] [Related]
3. [The cytogenetic and molecular genetic study of 81 multiple myeloma patients].
Li JT; Chang NB; Liu H; Pei L
Zhonghua Nei Ke Za Zhi; 2011 Dec; 50(12):1039-42. PubMed ID: 22333174
[TBL] [Abstract][Full Text] [Related]
4. Karyotypic abnormalities and their clinical aspects in multiple myeloma.
Scudla V; Jarosová M; Kapustová M; Indrák K; Smoldas J
Acta Univ Palacki Olomuc Fac Med; 1991; 129():69-79. PubMed ID: 1837676
[TBL] [Abstract][Full Text] [Related]
5. Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high-dose chemotherapy in patients with multiple myeloma.
Wu KL; Beverloo B; Lokhorst HM; Segeren CM; van der Holt B; Steijaert MM; Westveer PH; Poddighe PJ; Verhoef GE; Sonneveld P; ;
Br J Haematol; 2007 Feb; 136(4):615-23. PubMed ID: 17223915
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetic data as a prognostic factor in multiple myeloma patients: involvement of 1p12 region an adverse prognostic factor.
Panani AD; Ferti AD; Papaxoinis C; Raptis SA; Roussos Ch
Anticancer Res; 2004; 24(6):4141-6. PubMed ID: 15736465
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal aberrations of multiple myeloma in Chinese patients at diagnosis: a study by combined G-banding and multicolor spectral karyotyping.
Ng MH; Wong N; Lau TT; Tsang KS; Cheng SH; Chan NP; Tang SH; Lei KI; Leung Y
Oncol Rep; 2003; 10(3):587-91. PubMed ID: 12684628
[TBL] [Abstract][Full Text] [Related]
8. High frequencies of chromosomal aberrations in multiple myeloma and monoclonal gammopathy of undetermined significance in direct chromosome preparation.
Nilsson T; Lenhoff S; Rylander L; Höglund M; Turesson I; Mitelman F; Westin J; Johansson B
Br J Haematol; 2004 Aug; 126(4):487-94. PubMed ID: 15287940
[TBL] [Abstract][Full Text] [Related]
9. [Cytogenetic analysis on 1058 cases of acute nonlymphocytic leukemia].
Xue Y; Guo Y; Wu Y; Pan J; Li J; Lu D
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Aug; 18(4):247-50. PubMed ID: 11484158
[TBL] [Abstract][Full Text] [Related]
10. [Chromosome anomalies in Venezuelan patients with multiple myeloma].
Quintero M; Rojas-Atencio A; Ruiz A; González M; Herrera J; Atencio F; Delgado W; Urdaneta K; Pérez F
Invest Clin; 2003 Dec; 44(4):327-35. PubMed ID: 14727386
[TBL] [Abstract][Full Text] [Related]
11. [Cytogenetic characteristics of patients with multiple myeloma in China: analysis of 100 case].
Deng SH; Xu Y; Wang YF; Mai YJ; Liu XP; Zhao YZ; Zou DH; Wang Y; Qiu LG
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1685-8. PubMed ID: 17825148
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations.
Calasanz MJ; Cigudosa JC; Odero MD; Ferreira C; Ardanaz MT; Fraile A; Carrasco JL; Solé F; Cuesta B; Gullón A
Genes Chromosomes Cancer; 1997 Feb; 18(2):84-93. PubMed ID: 9115968
[TBL] [Abstract][Full Text] [Related]
13. [The significance and current diagnostic options of cytogenetic changes in multiple myeloma].
Kuglík P; Filková H; Oltová A; Hájek R
Vnitr Lek; 2006 Nov; 52 Suppl 2():76-8. PubMed ID: 18175433
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
15. [Cytogenetic study of multiple myeloma].
Zhang Y; Jiang B; Huang XJ; Shi Y; He Q; Dang H; Qiu JY; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):76-8. PubMed ID: 17490526
[TBL] [Abstract][Full Text] [Related]
16. [Establishment and biological characteristics of human multiple myeloma cell line CZ-1].
Hou J; Zhang B; Zhang L; Ding S
Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):509-13. PubMed ID: 12482345
[TBL] [Abstract][Full Text] [Related]
17. [The comparison of three cytogenetic methods for detecting multiple myeloma].
Ren J; Yang LH; Li GX; Fan JL; Hou J
Zhonghua Nei Ke Za Zhi; 2009 Sep; 48(9):737-40. PubMed ID: 20079209
[TBL] [Abstract][Full Text] [Related]
18. Conventional cytogenetics in myeloma.
Campbell LJ
Methods Mol Med; 2005; 113():37-47. PubMed ID: 15968093
[TBL] [Abstract][Full Text] [Related]
19. [Cytogenetic study in multiple myeloma. II. Clinical significance of chromosomal changes].
Scudla V; Jarosová M; Kapustová M; Indrák K
Vnitr Lek; 1990 Nov; 36(11):1081-91. PubMed ID: 2267738
[TBL] [Abstract][Full Text] [Related]
20. Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study.
Put N; Konings P; Rack K; Jamar M; Van Roy N; Libouton JM; Vannuffel P; Sartenaer D; Ameye G; Speleman F; Herens C; Poirel HA; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L;
Genes Chromosomes Cancer; 2009 Oct; 48(10):843-53. PubMed ID: 19582829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]